Penserra Capital Management LLC Unity Biotechnology, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$1.3 - $3.17 $1,638 - $3,994	-1,260 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.91 - $4.5 $29 - $45	10 Added 0.8%	1,260 $3,000
Q2 2021 Aug 12, 2021	BUY	$4.15 - $6.3 $166 - $252	40 Added 3.31%	1,250 $5,000
Q1 2021 May 13, 2021	SELL	$5.51 - $9.42 $27 - $47	-5 Reduced 0.41%	1,210 $7,000
Q4 2020 Feb 12, 2021	BUY	$3.42 - $6.36 $2,636 - $4,903	771 Added 173.65%	1,215 $6,000
Q3 2020 Nov 13, 2020	BUY	$2.94 - $12.43 $1,305 - $5,518	444 New	444 $1,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $20.6M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.